Literature DB >> 29611025

Expressions of some antioxidant genes in SH-SY5Y cells treated with β-lapachone, morphine and electromagnetic field.

Hamideh Mahmoudinasab1, Mostafa Saadat2.   

Abstract

β-Lapachone (β-Lap), morphine (Mor), and electromagnetic field (EMF) generate reactive oxygen species. The goal of the present study was to examine the effects of Mor and EMF, in combination with β-Lap on the cell growth inhibition and expression of several antioxidant genes. The 0.50 mT intensity of 50 Hz EMF and two exposure conditions ("15 min field-on/15 min field-off" and "30 min field-on continuously") on SH-SY5Y cells were used. The effects of Mor and EMF, in combination with β-Lap on cell growth inhibition and the expression levels of several antioxidant genes (NQO1, NQO2, SOD1, SOD2, CAT, GSTO1, GSTM2, GSTM3, GSTP1, MGST1, MGST3) in SH-SY5Y cells were measured. The relative mRNA levels were calculated according to the [Formula: see text]. Whereas NQO1 mRNA level decreased in the "15 min field-on/15 min field-off" condition, the expression level of NQO2 was increased. Both NQO1 and NQO2 expressions increased in Mor treated cells. IC50 values of β-Lap in combination with Mor, EMF, and "Mor + EMF" were higher than cells treated only with β-Lap. The NQO1 expression level in the cells treated with β-Lap was higher than the other treatments, indicating that β-Lap induces the expression of NQO1. Moreover, multiple linear regression analysis indicated that NQO1 mRNA levels were associated positively with β-Lap and negatively with EMF. At least in part, the mRNA levels of NQO1 were associated with IC50 values of β-Lap in designed treatments. There is a negative association between mRNA levels of NQO1 and IC50 values of β-Lap but not NQO2.

Entities:  

Keywords:  Combination therapy; Extremely low-frequency electromagnetic field; NQO1

Mesh:

Substances:

Year:  2018        PMID: 29611025     DOI: 10.1007/s11033-018-4172-1

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.742


  26 in total

1.  Guidelines for accurate EC50/IC50 estimation.

Authors:  J L Sebaugh
Journal:  Pharm Stat       Date:  2011 Mar-Apr       Impact factor: 1.894

2.  Evaluation of prooxidant-antioxidant balance in chronic heroin users in a single assay: an identification criterion for antioxidant supplementation.

Authors:  Leda Kovatsi; Samuel Njau; Kakia Nikolaou; Konstantina Topouridou; Theodora Papamitsou; George Koliakos
Journal:  Am J Drug Alcohol Abuse       Date:  2010-07       Impact factor: 3.829

3.  Expression patterns of antioxidant genes in human SH-SY5Y cells after treatment with methadone.

Authors:  Khyber Saify; Mostafa Saadat
Journal:  Psychiatry Res       Date:  2015-08-17       Impact factor: 3.222

4.  Effect of extremely low frequency of electromagnetic fields on cell proliferation, antioxidative enzyme activities and lipid peroxidation in 3T3-L1 preadipocytes--an in vitro study.

Authors:  K Zwirska-Korczala; J Jochem; M Adamczyk-Sowa; P Sowa; R Polaniak; E Birkner; M Latocha; K Pilc; R Suchanek
Journal:  J Physiol Pharmacol       Date:  2005-12       Impact factor: 3.011

Review 5.  NRH:quinone oxidoreductase2 (NQO2).

Authors:  D J Long; A K Jaiswal
Journal:  Chem Biol Interact       Date:  2000-12-01       Impact factor: 5.192

6.  Different profiles of the mRNA levels of DNA repair genes in MCF-7 and SH-SY5Y cells after treatment with combination of cisplatin, 50-Hz electromagnetic field and bleomycin.

Authors:  Fatemeh Sanie-Jahromi; Mostafa Saadat
Journal:  Biomed Pharmacother       Date:  2017-08-04       Impact factor: 6.529

Review 7.  Opportunities and challenges in combination gene cancer therapy.

Authors:  Kent L Nastiuk; John J Krolewski
Journal:  Adv Drug Deliv Rev       Date:  2015-12-23       Impact factor: 15.470

8.  Induction of genomic instability, oxidative processes, and mitochondrial activity by 50Hz magnetic fields in human SH-SY5Y neuroblastoma cells.

Authors:  Jukka Luukkonen; Anu Liimatainen; Jukka Juutilainen; Jonne Naarala
Journal:  Mutat Res       Date:  2013-12-26       Impact factor: 2.433

9.  NAD(P)H:Quinone oxidoreductase activity is the principal determinant of beta-lapachone cytotoxicity.

Authors:  J J Pink; S M Planchon; C Tagliarino; M E Varnes; D Siegel; D A Boothman
Journal:  J Biol Chem       Date:  2000-02-25       Impact factor: 5.486

10.  Upregulation of NAD(P)H:quinone oxidoreductase by radiation potentiates the effect of bioreductive beta-lapachone on cancer cells.

Authors:  Eun K Choi; Kaoru Terai; In-Mi Ji; Yeon H Kook; Kyung H Park; Eun T Oh; Robert J Griffin; Byung U Lim; Jin-Seok Kim; Doo S Lee; David A Boothman; Melissa Loren; Chang W Song; Heon Joo Park
Journal:  Neoplasia       Date:  2007-08       Impact factor: 6.218

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.